Class I

Latest Articles

Article
Lasmiditan is an effective acute treatment for migraineA phase 3 randomized study
Bernice Kuca, Stephen D. Silberstein, Linda Wietecha, et al.

Neurology November 16, 2018
Article
Galcanezumab in chronic migraineThe randomized, double-blind, placebo-controlled REGAIN study
Holland C. Detke, Peter J. Goadsby, Shufang Wang, et al.

Neurology November 16, 2018
Article
Safety and efficacy of venoplasty in MSA randomized, double-blind, sham-controlled phase II trial
Anthony L. Traboulsee, Lindsay Machan, J. Marc Girard, et al.

Neurology September 28, 2018
Editorial
Venoplasty in MSTherapeutic intervention without any evidence
Friedemann Paul, Mike P. Wattjes

Neurology September 28, 2018